Latest Artal Group S.A. Stock Portfolio
$3.92Billion– No. of Holdings #109
Artal Group S.A. Performance:
2024 Q2: -9.71%YTD: -3.22%2023: 2.64%
Performance for 2024 Q2 is -9.71%, and YTD is -3.22%, and 2023 is 2.64%.
About Artal Group S.A. and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Artal Group S.A. reported an equity portfolio of $3.9 Billions as of 30 Jun, 2024.
The top stock holdings of Artal Group S.A. are , LXRX, SRRK. The fund has invested 55.6% of it's portfolio in CAVA GROUP INC and 7.5% of portfolio in LEXICON PHARMACEUTICALS INC.
The fund managers got completely rid off MADRIGAL PHARMACEUTICALS INC (MDGL), VIKING THERAPEUTICS INC (VKTX) and ALPINE IMMUNE SCIENCES INC (ALPN) stocks. They significantly reduced their stock positions in ADOBE INC (ADBE), TOURMALINE BIO INC and SEA LTD (SE). Artal Group S.A. opened new stock positions in AVIDITY BIOSCIENCES INC (RNA), CULLINAN THERAPEUTICS INC (CGEM) and ASCENDIS PHARMA A/S. The fund showed a lot of confidence in some stocks as they added substantially to VISA INC (V), MICROSOFT CORP (MSFT) and JANUX THERAPEUTICS INC (JANX).
The top stock holdings of Artal Group S.A. are , LXRX, SRRK. The fund has invested 55.6% of it's portfolio in CAVA GROUP INC and 7.5% of portfolio in LEXICON PHARMACEUTICALS INC.
The fund managers got completely rid off MADRIGAL PHARMACEUTICALS INC (MDGL), VIKING THERAPEUTICS INC (VKTX) and ALPINE IMMUNE SCIENCES INC (ALPN) stocks. They significantly reduced their stock positions in ADOBE INC (ADBE), TOURMALINE BIO INC and SEA LTD (SE). Artal Group S.A. opened new stock positions in AVIDITY BIOSCIENCES INC (RNA), CULLINAN THERAPEUTICS INC (CGEM) and ASCENDIS PHARMA A/S. The fund showed a lot of confidence in some stocks as they added substantially to VISA INC (V), MICROSOFT CORP (MSFT) and JANUX THERAPEUTICS INC (JANX).
Artal Group S.A. Equity Portfolio Value
Last Reported on: 14 Aug, 2024
Artal Group S.A. Annual Return Estimates Vs S&P 500
Our best estimate is that Artal Group S.A. made a return of -9.71% in the last quarter. In trailing 12 months, it's portfolio return was -3.61%.
New Buys
| Ticker | $ Bought |
|---|---|
| avidity biosciences inc | 26,779,400 |
| cullinan therapeutics inc | 18,450,600 |
| ascendis pharma a/s | 13,788,000 |
| agenus inc | 12,981,200 |
| biohaven ltd | 10,645,700 |
| cartesian therapeutics inc | 8,226,000 |
| rapport therapeutics inc | 8,141,000 |
| iovance biotherapeutics inc | 8,112,230 |
New stocks bought by Artal Group S.A.
Additions
| Ticker | % Inc. |
|---|---|
| visa inc | 660 |
| microsoft corp | 352 |
| janux therapeutics inc | 306 |
| procore technologies inc | 240 |
| dynatrace inc | 202 |
| datadog inc | 201 |
| gritstone bio inc | 194 |
| fate therapeutics inc | 186 |
Additions to existing portfolio by Artal Group S.A.
Reductions
| Ticker | % Reduced |
|---|---|
| adobe inc | -70.97 |
| tourmaline bio inc | -70.93 |
| dlocal ltd | -65.06 |
| sea ltd | -58.95 |
| intapp inc | -55.93 |
| pepgen inc | -43.34 |
| elevation oncology inc | -33.05 |
| beigene ltd | -25.05 |
Artal Group S.A. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| cartesian therapeutics inc | -5,938,810 |
| geron corp | -4,227,940 |
| adagene inc | -2,856,000 |
| amicus therapeutics inc | -11,918,700 |
| vor biopharma inc | -2,370,000 |
| astria therapeutics inc | -12,445,300 |
| agenus inc | -9,066,120 |
| repare therapeutics inc | -3,297,000 |
Artal Group S.A. got rid off the above stocks
Sector Distribution
Artal Group S.A. has about 60.7% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 60.7 |
| Healthcare | 38.2 |
Market Cap. Distribution
Artal Group S.A. has about 1.7% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 61.1 |
| MID-CAP | 17.9 |
| SMALL-CAP | 16.4 |
| MICRO-CAP | 2.1 |
| MEGA-CAP | 1.7 |
Stocks belong to which Index?
About 30.7% of the stocks held by Artal Group S.A. either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 68.6 |
| RUSSELL 2000 | 30.7 |
Artal Group S.A. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Artal Group S.A.
Artal Group S.A. has 109 stocks in it's portfolio. About 77.5% of the portfolio is in top 10 stocks. SRRK proved to be the most loss making stock for the portfolio. DYN was the most profitable stock for Artal Group S.A. last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AAPL | apple inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ACHL | achilles therapeutics plc | 0.02 | 755,375 | 615,631 | unchanged | 0.00 | ||
| ADBE | adobe inc | 0.01 | 900 | 499,986 | reduced | -70.97 | ||
| ADCT | adc therapeutics sa | 0.08 | 1,018,460 | 3,218,340 | new | |||
| AGEN | agenus inc | 0.33 | 775,000 | 12,981,200 | new | |||
| AGEN | agenus inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALPN | alpine immune sciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALVR | allovir inc | 0.12 | 6,597,170 | 4,771,730 | unchanged | 0.00 | ||
| AMD | advanced micro devices inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AMZN | amazon com inc | 0.10 | 19,250 | 3,720,060 | added | 60.42 | ||
| APLS | apellis pharmaceuticals inc | 1.44 | 1,467,080 | 56,277,200 | added | 11.54 | ||
| APLT | applied therapeutics inc | 0.12 | 1,009,500 | 4,714,360 | unchanged | 0.00 | ||
| ARWR | arrowhead pharmaceuticals inc | 2.11 | 3,189,390 | 82,892,200 | added | 5.03 | ||
| ATXS | astria therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AVTE | aerovate therapeutics inc | 0.03 | 809,600 | 1,343,940 | new | |||
| AXSM | axsome therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BDTX | black diamond therapeutics inc | 0.12 | 1,046,520 | 4,876,770 | unchanged | 0.00 | ||
| BEKE | ke holdings inc | 0.08 | 225,000 | 3,183,750 | reduced | -18.18 | ||
| BGNE | beigene ltd | 1.10 | 303,369 | 43,281,700 | reduced | -25.05 | ||
| BZ | kanzhun ltd | 0.02 | 50,000 | 940,500 | new | |||